Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 01 Oct 2026. Factsheet Jun 2026. About · Disclosures
Tata India Pharma and Healthcare Fund Direct Plan Growth
Tata Mutual Fund₹38.0577
As on 01 Oct 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +7.91% | — | — |
| 3 year | +18.54% | — | — |
| 5 year | +13.72% | — | — |
- Sharpe
- 0.88
- Std dev
- 16.38%
- Beta
- 0.99
Returns
From NAVs through 01 Oct 2026
Calendar years
Rolling 1-year · 51 overlapping windows
Fund facts
Fund details from the Jun 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
42 holdings · portfolio as on 30 May 2026
- 9.38%Sun Pharmaceuticals Industries LtdHealthcare
- 5.87%Healthcare Global Enterprises LtdHealthcare
- 5.8%Divi's Laboratories LtdHealthcare
- 5.41%Abbott India LtdHealthcare
- 5.18%Cipla LtdHealthcare
- 4.8%Max Healthcare Institute Ltd Ordinary SharesHealthcare
- 4.56%Apollo Hospitals Enterprise LtdHealthcare
- 4.52%Rainbow Childrens Medicare LtdHealthcare
- 4.02%Dr Reddy's Laboratories LtdHealthcare
- 3.77%Mankind Pharma LtdHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
Who manages this fund
1 fund manager
- RSRajat Srivastava1.4 years in the industryRuns 1 scheme
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
FAQ
What is Tata India Pharma and Healthcare Fund Direct Plan Growth NAV today?
- The latest NAV of Tata India Pharma and Healthcare Fund Direct Plan Growth is ₹38.0577 as on 01 Oct 2026.
How has Tata India Pharma and Healthcare Fund Direct Plan Growth performed vs its category?
- 1-year return +7.91%. Past performance does not guarantee future returns.
What are the returns of Tata India Pharma and Healthcare Fund Direct Plan Growth?
- Trailing returns from published NAVs: 1 year +7.91%, 3 year +18.54% a year, 5 year +13.72% a year, since our first NAV +14.73% a year. Past performance does not guarantee future returns.
How would a SIP in Tata India Pharma and Healthcare Fund Direct Plan Growth have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +18.54%. It is not a forecast.
What is the expense ratio and fund size of Tata India Pharma and Healthcare Fund Direct Plan Growth?
- For Tata India Pharma and Healthcare Fund Direct Plan Growth, the expense ratio is 0.67% and fund size (AUM) is ₹1386.99 Cr.
What is the ISIN of Tata India Pharma and Healthcare Fund Direct Plan Growth?
- The ISIN for Tata India Pharma and Healthcare Fund Direct Plan Growth is INF277K019A3.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.